Cabinet Clears Rs 15 Billion Biomedical Research Career Phase III

03 Oct 2025 CW Team

Launched in 2008–09 through the DBT/Wellcome Trust India Alliance, the BRCP has been instrumental in supporting world-class biomedical research in India. Phase II was rolled out in 2018–19 with an expanded portfolio, and Phase III will build on this foundation to nurture scientific talent, foster translational innovation, and reduce regional disparities in research capacity.

Phase III will introduce:

Early Career and Intermediate Fellowships in basic, clinical and public health, tailored for formative stages of scientists.
Collaborative Grants, including Career Development and Catalytic Collaborative Grants for early and mid-senior researchers with strong track records.
Research Management Programme to strengthen core research efforts, mentorship, networking, public engagement and international collaborations.

The programme aims to train over 2,000 students and postdoctoral fellows, deliver high-impact publications, enable patentable discoveries, and provide stronger support for women researchers (10–15 per cent increase). It also targets 25–30 per cent of collaborative programmes advancing to Technology Readiness Level (TRL) 4 or above, while expanding engagement in Tier-2 and Tier-3 regions.

Phases I and II established India as an emerging hub for biomedical sciences of global standing. Phase III, aligned with Viksit Bharat goals, will strengthen India’s biomedical research ecosystem, enhance innovation, and cement its place in the global knowledge economy.

The Union Cabinet chaired by Prime Minister Narendra Modi has approved the continuation of the Biomedical Research Career Programme (BRCP) Phase III, a joint initiative of the Department of Biotechnology (DBT), Government of India, and the Wellcome Trust (WT), United Kingdom. The programme will run from 2025–26 to 2030–31, with an additional six years (2031–32 to 2037–38) to service fellowships and grants, at a total cost of Rs 15 billion, of which DBT will contribute Rs 10 billion and WT Rs 5 billion.Launched in 2008–09 through the DBT/Wellcome Trust India Alliance, the BRCP has been instrumental in supporting world-class biomedical research in India. Phase II was rolled out in 2018–19 with an expanded portfolio, and Phase III will build on this foundation to nurture scientific talent, foster translational innovation, and reduce regional disparities in research capacity.Phase III will introduce:Early Career and Intermediate Fellowships in basic, clinical and public health, tailored for formative stages of scientists.Collaborative Grants, including Career Development and Catalytic Collaborative Grants for early and mid-senior researchers with strong track records.Research Management Programme to strengthen core research efforts, mentorship, networking, public engagement and international collaborations.The programme aims to train over 2,000 students and postdoctoral fellows, deliver high-impact publications, enable patentable discoveries, and provide stronger support for women researchers (10–15 per cent increase). It also targets 25–30 per cent of collaborative programmes advancing to Technology Readiness Level (TRL) 4 or above, while expanding engagement in Tier-2 and Tier-3 regions.Phases I and II established India as an emerging hub for biomedical sciences of global standing. Phase III, aligned with Viksit Bharat goals, will strengthen India’s biomedical research ecosystem, enhance innovation, and cement its place in the global knowledge economy.

Infrastructure Energy

17 Dec 2025

Vedanta Aluminium Uses 1.57 bn Units of Green Energy in FY25

Vedanta Aluminium, India’s largest aluminium producer, recently reported consumption of 1.57 billion units of renewable energy in FY25, marking a significant milestone in its 2030 decarbonisation roadmap. The company also achieved an 8.96 per cent reduction in greenhouse gas (GHG) emissions intensity compared to FY21, reinforcing its leadership in India’s low-carbon manufacturing transition. During FY25, Vedanta Aluminium expanded its renewable energy portfolio through long-term power purchase agreements, strengthening its strategy to source nearly 1,500 MW of renewable power over the lon..

Real Estate

17 Dec 2025

Oberoi Group to Develop Luxury Resort at Makaibari Tea Estate

EIH Limited, the flagship company of The Oberoi Group, has announced the signing of a management agreement to develop an Oberoi luxury resort at the iconic Makaibari Tea Estate in Darjeeling. The project marks a key milestone in the Group’s long-term strategy of creating distinctive hospitality experiences in rare and environmentally significant locations. Established in 1859, Makaibari is one of the world’s oldest tea estates and is globally recognised for its Himalayan landscape, primary forests and exceptional biodiversity. Spread across 1,236 acres, the estate houses one of the world�..

Real Estate

17 Dec 2025

GHV Infra Secures Rs 1.09 Bn EPC Order in Jamshedpur

GHV Infra Projects Ltd, a fast-growing EPC company in India’s infrastructure and construction sector, has recently secured a Rs 1.09 billion work order in Jamshedpur, Jharkhand. Awarded by a reputed group entity, the contract covers end-to-end civil construction, mechanical, electrical and plumbing (MEP) systems, along with high-quality finishing works for a large building development. The project will be executed over a 30-month period, with defined benchmarks for quality, safety and timely delivery. The order strengthens GHV Infra’s footprint in Jamshedpur, a key industrial hub known fo..